MAP Pharma (MAPP) Misses Q4 Views by 2c
Tweet Send to a FriendGet Alerts MAPP Hot Sheet
Price: $24.98 --0%
EPS Growth %: 0.0%
Financial Fact:
Collaboration revenue: 878K
Today's EPS Names:
CSS, STV, GIGM, More
EPS Growth %: 0.0%
Financial Fact:
Collaboration revenue: 878K
Today's EPS Names:
CSS, STV, GIGM, More
Trade MAPP Now!
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q4 loss of $0.46, 2 cents worse than the analyst estimate of ($0.44).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Medtronic, Inc. (MDT) Tops Q4 EPS by 7c; Guides FY14
- Universal Corp. (UVV) Reports Q4 EPS of $0.92
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
